HOME >> MEDICINE >> NEWS
GroPep awarded key patent for infertility treatment in Europe

Adelaide biotechnology company, GroPep, has achieved a major development milestone in its infertility drug program with the granting of European patent number 1028743.

The patent covering GroPep's drug for the treatment of recurrent miscarriage provides the company with a European market patent exclusivity until at least 2018. GroPep already has two US patents covering the active ingredient of the drug until 2020.

According to the American College of Obstetricians and Gynecologists, at least 50 percent of recurrent miscarriages have no apparent explanation and there is no cure. The size of the market, the lack of competition and the strong patent position held by GroPep, means that the drug has the potential to participate in a market worth up to US$750 million annually.

Listed biopharmaceutical company GroPep Limited (ASX: GRO) today announced that European Patent No. 1028743, covering a method of treating recurrent miscarriage and preeclampsia using GroPep's infertility drug product - PV903, has been granted.

This patent grant is a major product development milestone as it provides the Company with a European market patent exclusivity until at least 2018. The European patent compliments two granted US patents licensed to GroPep by OSI Pharmaceuticals that cover the active ingredient of PV903 and method of manufacture until at least 2020. The combination provides GroPep with patent protection in the world's most valuable markets. The Company is also prosecuting additional patent applications to further extend the patent protection around PV903.

GroPep's Chief Executive Officer, Mr Bob Finder, said that the Company is developing PV903 as a potential treatment for recurrent miscarriage, a traumatic infertility condition with an estimated market potential of over US$750 million per year. There are currently no drugs approved for the treatment of recurrent miscarriage.

The European patent is owned by the Univers
'"/>

Contact: Tony Mitchell
61-88-354-7700
Research Australia
26-Jul-2006


Page: 1 2

Related medicine news :

1. GroPep starts Phase 1 infertility trial
2. GroPep completes final milestone of the path malaria vaccine initiative
3. GroPep to pursue promising asthma drug following preclinical study results
4. GroPep licenses technology to TGR BioSciences
5. GroPep news: Key psoriasis patent granted in Japan and new asthma patent filed for GroPep drug
6. UCLA researchers awarded $9M contract for study identifiying antibiotic treatment for MRSA
7. LSUHSC awarded designation resulting in improved patient safety and outcomes
8. Scripps Research awarded $17 million for adult stem cell use to treat eye diseases
9. UIC awarded $7M NIH grant for infertility research
10. $2.6M grant awarded to New York University College of Nursing
11. Greenberg Prize awarded to Dr. Joseph G. Hayes

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/17/2019)... ... February 18, 2019 , ... ... Seal of Approval® for Health Care Staffing Services Certification. The certification demonstrates Highland ... , “Highland Medical Group is pleased to receive certification from The Joint Commission, ...
(Date:2/14/2019)... LAND, Texas (PRWEB) , ... February 14, 2019 ... ... Las Vegas, QT Medical announced the launch of its Personal Cardiac Assistant (PCA ... Several health trackers including Apple Watch 4 can record single lead ECGs and ...
(Date:2/13/2019)... ... February 13, 2019 , ... ... school locker rooms. Unfortunately, bullies also frequent hospital units, ambulatory care centers, clinics, ... , In this fully updated, second edition of What to Do When Nurses ...
(Date:2/13/2019)... ... 13, 2019 , ... Diameter Health , the leader in clinical data ... Security Management Act (FISMA) High General Support System Authority to Operate (ATO) for Diameter ... mandatory for the VA because of their work with confidential patient data. Protecting this ...
(Date:2/13/2019)... ... February 13, 2019 , ... Dr. Jig Patel and the dental ... an exceptionally talented and knowledgeable dentist from St. Louis, MO, to the ... such as CEREC same-day dentistry, root canals and emergency treatment. Dr. Patel, Dr. Merchant ...
Breaking Medicine News(10 mins):
(Date:2/13/2019)... ... 2019 , ... Researchers from the Icahn School of Medicine at Mount Sinai ... of the National Institutes of Health (NIH), for a five-year program called the U19 ... are to establish follicle-stimulating hormone (FSH), an important part of the reproductive system whose ...
(Date:2/13/2019)... ... February 13, 2019 , ... ... Vision Source ® as the recipients for the ‘Empower Your Care Teams ... which were announced at the 2019 HIMSS Annual Conference and Exhibition ...
(Date:2/13/2019)... ... 13, 2019 , ... Sensible Surrogacy today has launched a ... childless couples who are unable to afford the staggering cost of surrogacy in ... North America or Eastern Europe for legal and secure surrogacy procedures. However North ...
Breaking Medicine Technology:
Cached News: